The early state of invasive pancreatic ductal adenocarcinomas: Characteristics of the low papillary type and flat type intraductal carcinoma

Pancreas

Volumn 33, Issue 2, 2006, Pages 135-141

  Ikeda, Masaki ^a,b   Yanagisawa, Akio ^c   Seki, Makoto ^a   Sasaki, Keiko ^a   Takano, Kouichi ^a   Kato, Yo ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Early state; Invasive pancreatic ductal adenocarcinomas; Noninvasive intraductal carcinoma; Noninvasive intraductal spread; Pancreatic intraepithelial neoplasia

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIXED TUMOR; PANCREAS ADENOCARCINOMA; PAPILLARY CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33746781720     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000227911.63579.5c     Document Type: Article

References (27)

1. Yanagisawa A, Kato Y, Ohtake K, et al. c-Ki-ras point mutation in ductectatic type mucinous cystic neoplasm of the pancreas. Jpn J Cancer Res. 1991;82:1057-1060.
2. Yanagisawa A, Ohtake K, Ohashi K. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res. 1993;53:953-956.
3. Yanagisawa A, Ohashi K, Hori M, et al. Ductectatic-type mucinous cystadenoma and cystadenocarcinoma of the human pancreas: a novel clinicopathological entity. Jpn J Cancer Res. 1993;84:474-479.
4. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepitherial neoplasia. A nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579-586.
5. Hruban RH, Takatori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28(8):977-987.
6. Longnecker DS, Adsay NV, Fernandez-del Castillo C, et al. Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement. Pancreas. 2005;31(4):344-349.
7. Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumors. 6th ed. New York, NY: Wiley-Liss Inc; 2002.
8. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res. 1976;36:2690-2698.
9. Kozuka S, Sassa R, Taki T, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer. 1979;43:1418-1428.
10. Klöppel G, Bommer G, Rückert K, et al. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch A Pathol Anat Histol. 1980;387:221-233.
11. Sommers SG, Murphy SA, Warren S. Pancreatic duct hyperplasia and cancer. Gastroenterology. 1954;27:629-640.
12. Chen J, Baithun SI, Ramsay MA. Histogenesis of pancreatic carcinomas: a study based on 248 cases. J Pathol. 1985;146:65-76.
13. Pour PM, Sayed S, Sayed G. Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreas. Am J Clin Pathol. 1982;77:137-152.
14. Stamm BH. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum Pathol. 1984;15:677-683.
15. Furukawa T, Chiba R, Kobari M, et al. Varying grade of epithelial atypia in the pancreatic ducts of humans. Arch Pathol Lab Med. 1994;118:227-234.
16. Obara T, Saitoh Y, Maguchi H. Multicentric development of pancreatic intraductal carcinoma through atypical papillary hyperplasia. Hum Pathol. 1992;23(1):82-85.
17. Klimstra DS, Longnecker DS. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol. 1994;145:1547-1550.
18. Moskaluk CA, Hruban RH, Kern SE. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res. 1997;57:2140-2143.
19. Terhune PG, Phifer DM, Tosteson TD, et al. K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev. 1998;7:515-521.
20. Wilentz RE, Geradts J, Maynard R, et al. Inactivation of the p16 (INK 4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res. 1998;58:4740-4744.
21. Heinmoller E, Dietmaier W, Zirngibl H, et al. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol. 2000;157:83-92.
22. Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 2000;60:2002-2006.
23. Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Surg Pathol. 2000;156:1821-1825.
24. Fukushige S, Furukawa T, Satoh K, et al. Loss of chromosome 18q is an early event in pancreatic ductal tumors. Cancer Res. 1998;58:4222-4226.
25. Inoue H, Furukawa T, Sunamura M, et al. Exclusion of SMAD 4 mutation as an early genetic change in human pancreatic ductal tumor genesis. Genes Chromosomes Cancer. 2001;31:295-299.
26. Hilgers W, Song JJ, Haye M, et al. Homozygous deletions inactive DCC, but not MADH 4/ DPC 4/ MAD 4, in a subset of pancreatic and biliary cancers. Genes Chromosomes Cancer. 2000;27:353-357.
27. Yamano M, Fujii H, Takagi T, et al. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol. 2000;156:2123-2133.